BACE1 and Alzheimer disease: In AD, excessive TNF-α activated TNFR1 through high affinity binding [9] and signaling accordingly suppresses Aβ degradation by reducing the expression of insulin degrading enzyme [30] and affects Aβ production through upregulation of BACE expression [31] and γ-secretase activity [32].